Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 352 | 301 | 104 | 52 | 248 |
| Receivables | 75 | 80 | 110 | 102 | 11 |
| TOTAL | $544 | $438 | $305 | $238 | $410 |
| Non-Current Assets | |||||
| PPE Net | 53 | 67 | 79 | 94 | 118 |
| Other Non-Current Assets | 34 | 30 | 30 | 30 | 30 |
| TOTAL | $87 | $97 | $109 | $124 | $148 |
| Total Assets | $631 | $535 | $414 | $362 | $558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,796 | 3,301 | 2,338 | 1,816 | 1,453 |
| Accrued Expenses | 953 | 936 | 883 | 989 | 1,011 |
| Other current liabilities | 604 | N/A | N/A | N/A | N/A |
| TOTAL | $12,046 | $10,008 | $8,105 | $6,815 | $5,763 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 35 |
| TOTAL | $3 | $4 | $5 | $7 | $12 |
| Total Liabilities | $12,049 | $10,012 | $8,110 | $6,822 | $5,775 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 244 | 80 | 80 | 80 | 79 |
| Common Shares | 19 | 19 | 19 | 19 | 19 |
| Retained earnings | -82,690 | -80,703 | -77,921 | -75,279 | -72,753 |
| Other shareholders' equity | 33 | 0 | 0 | -3 | -7 |
| TOTAL | $-11,418 | $-9,477 | $-7,696 | $-6,460 | $-5,217 |
| Total Liabilities And Equity | $631 | $535 | $414 | $362 | $558 |